Published in J Biol Chem on December 01, 1953
The isolation of a new lipid, triphosphoinositide, and monophosphoinositide from ox brain. Biochem J (1961) 3.11
Liver glycerylphosphorylcholine diesterase. Biochem J (1956) 2.71
Separation and composition of the phospholipids of ox heart. Biochem J (1958) 2.63
The phospholipase B of liver. Biochem J (1956) 2.31
Physiologically active choline esters in certain marine gastropods and other invertebrates. J Physiol (1957) 2.14
Some properties of purified phospholipase D and especially the effect of amphipathic substances. Biochem J (1967) 2.08
Distribution of fatty acids in lipids of rat brain, brain mitochondria and microsomes. Biochem J (1961) 1.95
Glycerylphosphorylcholine and phosphorylcholine in semen, and their relation to choline. Biochem J (1957) 1.73
Effect of the hemolysin of Pseudomonas aeruginosa on phosphatides and on phospholipase c activity. J Bacteriol (1967) 1.62
Ethionine administration in the rat. 2. Effects on the incorporation of [P]orthophosphate and dl-[1-C]leucine into the phosphatides and proteins of liver and plasma. Biochem J (1961) 1.33
Studies on phospholipids. 3. Determination of choline. Biochem J (1958) 1.31
The reported occurrence of sphingosylphosphorylcholine in animal tissues. Biochem J (1958) 1.29
The structure of C-polysaccharide from the walls of Streptococcus pneumoniae. Biochem J (1978) 1.21
Glycerylphosphorylcholine diesterase activity of nervous tissue. Biochem J (1957) 1.12
The distribution of phospholipase B in mammalian tissues. Biochem J (1960) 1.10
The participation of phospholipids in the interaction of leucocidin and the cell membrane of the polymorphonuclear leucocyte. Biochem J (1967) 1.08
The action of cabbage-leaf phospholipase D upon lysolecithin. Biochem J (1967) 1.07
Staphylococcal beta-hemolysin. II. Phospholipase C activity of purified beta-hemolysin. J Bacteriol (1967) 1.02
A study of vitamin B12 protection in experimental thyrotoxicosis in the rat. Biochem J (1959) 0.97
The heterogeneity of bound acetylcholine and synaptic vesicles. Biochem J (1972) 0.97
Choline metabolism and membrane formation in rat hepatoma cells grown in suspension culture. II. Phosphatidylcholine synthesis during growth cycle and fluctuation of mitochondrial density. J Cell Biol (1969) 0.97
A role for phospholipids in the binding and metabolism of drugs by hepatic microsomes. Use of the fluorescent hydrophobic probe 1-anilinonaphthalene-8-sulphonate. Biochem J (1971) 0.94
Metabolism of Sinapine in Mustard Plants. I. Degradation of Sinapine into Sinapic Acid & Choline. Plant Physiol (1963) 0.90
Metabolism of acetylcholine in the nervous system of Aplysia californica. I. Source of choline and its uptake by intact nervous tissue. J Gen Physiol (1975) 0.88
Choline kinase in Cuscuta reflexa. Biochem J (1972) 0.87
The subcellular distribution of (N-Me-3H)acetylcholine synthesized by brain in vivo. Biochem J (1969) 0.87
The mechanism of fructose formation in goat placenta with special reference to the possible involvement of sorbitol or of phosphoric acid esters. Biochem J (1961) 0.87
Phosphate esters in the uterus. Biochem J (1958) 0.83
Isolation and enzymic assay of choline and phosphocholine present in cell extracts with picomole sensitivity. Biochem J (1990) 0.83
On the insensitivity of sheep to the almost complete microbial destruction of dietary choline before alimentary-tract absorption. Biochem J (1981) 0.81
The occurence of a long-chain ether analogue of phosphatidylethanolamine in brain tissue. Biochem J (1963) 0.78
Studies on the phospholipidsplitting enzyme of Vibrio El Tor. Biochem J (1962) 0.77
REVISED PROCEDURE FOR THE DETERMINATION OF "SPHINGOMYELIN" IN FRESH AND FORMALDEHYDE-PRESERVED TISSUE. Acta Neuropathol (1964) 0.75
A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem (1952) 18.27
The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest (1955) 6.74
Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem (1954) 5.08
The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem (1958) 4.90
Identification and assay of serotonin in brain. J Pharmacol Exp Ther (1956) 4.17
The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther (1957) 3.99
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60
Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med (1960) 3.26
Studies on the carbohydrate and protein metabolism of the rat hepatoma. Cancer Res (1951) 3.23
On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther (1959) 3.16
Some physico-chemical factors in drug action. J Pharm Pharmacol (1957) 3.13
Andrenergic receptive mechanism of canine ileum. J Pharmacol Exp Ther (1959) 3.05
The fate of antipyrine in man. J Pharmacol Exp Ther (1950) 3.05
Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03
The direct determination of phosphatidyl ethanolamine and phosphatidyl serine in plasma and red blood cells. J Biol Chem (1953) 2.98
Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem (1954) 2.78
INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther (1965) 2.77
A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci (1957) 2.71
Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther (1958) 2.62
The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther (1950) 2.54
The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther (1957) 2.46
The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38
Enzymatic metabolism of drugs and other foreign compounds. Annu Rev Biochem (1958) 2.36
Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20
Detoxication of drugs and other foreign compounds by liver microsomes. Science (1955) 2.20
Estimation of intracellular water in man. Am J Physiol (1950) 2.14
An enzymatic spectrophotometric method for the determination of phenylalanine in blood. J Lab Clin Med (1960) 2.14
Evidence that serotonin has a role in brain function. Science (1955) 2.13
Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther (1960) 2.10
The fate of thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1950) 2.10
THE ADRENERGIC RECEPTIVE MECHANISM OF THE RAT UTERUS. J Pharmacol Exp Ther (1963) 2.05
The calculation of transfer rates in two compartment systems not in dynamic equilibrium. J Gen Physiol (1958) 2.05
An analysis of adrenergic blocking activity. J Pharmacol Exp Ther (1961) 2.02
Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99
Measurement of total body chloride. Proc Soc Exp Biol Med (1951) 1.90
Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther (1957) 1.86
Absorption of drugs from the stomach. II. The human. J Pharmacol Exp Ther (1957) 1.85
Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate. J Pharmacol Exp Ther (1954) 1.78
Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J Biol Chem (1955) 1.77
The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76
ALTERATIONS OF ADRENERGIC RESPONSES BY N-ISOPROPYLMETHOXAMINE. J Pharmacol Exp Ther (1964) 1.70
Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther (1959) 1.63
The physiological disposition and metabolic fate of cortisone in man. J Clin Invest (1957) 1.62
On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J Pharmacol Exp Ther (1956) 1.61
Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. J Pharmacol Exp Ther (1956) 1.59
The enzymatic metabolism of hexobarbital (evipal). J Pharmacol Exp Ther (1955) 1.56
Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science (1957) 1.54
Alcaptonuria and ochronosis; with a report of three patients and metabolic studies in two. Am J Med (1952) 1.53
A study of sympathetic ganglionic stimulants. J Pharmacol Exp Ther (1962) 1.51
The value of anti-histamine drugs in the treatment of infective arthritis and Reiter's disease. J R Army Med Corps (1951) 1.51
Determination of histidine alpha-deaminase in human stratum corneum and its absence in histidinaemia. Biochem J (1963) 1.50
Total body water in man. Am J Physiol (1950) 1.50
Inhibitory effects of beta-diethylaminoethyl diphenylpropylacetate on a variety of drug metabolic pathways in vitro. J Pharmacol Exp Ther (1954) 1.49
The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid. J Pharmacol Exp Ther (1960) 1.47
RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE. Circulation (1963) 1.44
On the mechanism of antidepressant action of imipraminelike drugs. Ann N Y Acad Sci (1962) 1.42
The use of procaine amide in cardiac arrhythmias. Circulation (1951) 1.42
The tyrosine oxidation system of liver. II. Oxidation of p-hydroxyphenylpyruvic acid to homogentisic acid. J Biol Chem (1955) 1.42
Pathways of drug metabolism. J Pharm Pharmacol (1956) 1.41
Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835). J Pharmacol Exp Ther (1960) 1.41
The mechanism of serotonin and catecholamine uptake by platelets. J Pharmacol Exp Ther (1959) 1.40
Role of brain serotonin in reserpine action. Ann N Y Acad Sci (1957) 1.40
Structural requirements for bretylium and guanethidine-like activity. Life Sci (1962) 1.39
Aplastic anemia subsequent to sulfonamide administration. N Y State J Med (1950) 1.39
Release of serotonin from blood platelets by reserpine in vitro. J Pharmacol Exp Ther (1957) 1.39
The enzymatic reduction of chloramphenicol, p-nitrobenzoic acid and other aromatic nitro compounds in mammals. J Pharmacol Exp Ther (1957) 1.38
Metabolism of drugs in subjects with Laennec's cirrhosis. Med Exp Int J Exp Med (1959) 1.38
Postoperative pain; its use in the comparative evaluation of analgesics. Surgery (1952) 1.38
Assay of serotonin and related metabolites, enzymes, and drugs. Methods Biochem Anal (1958) 1.37
An enzymatic spectrophotometric method for the determination of homogentisic acid in plasma and urine. J Biol Chem (1961) 1.37
Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain. J Neurochem (1961) 1.35
The physiological disposition and biotransformation of dibenamine and a method for its estimation in biological tissues. J Pharmacol Exp Ther (1952) 1.35
The role of body fat in limiting the duration of action of thiopental. J Pharmacol Exp Ther (1952) 1.32
Suppression of sodium excretion by the colon in congestive heart failure and cirrhosis of the liver demonstrated by the use of cation exchange resins. J Clin Invest (1952) 1.29
Reserpine and guanethidine action on peripheral stores of catecholamines. Life Sci (1962) 1.27
Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone. Am J Med (1954) 1.22
Effects of reserpine and cold-exposure on pituitary-adrenocortical function in rats. J Pharmacol Exp Ther (1961) 1.21
Studies on the defect in tyrosine metabolism in scorbutic guinea pigs. J Biol Chem (1960) 1.19
THE ACTIONS OF RESERPINE, GUANETHIDINE AND METARAMINOL ON CARDIAC CATECHOLAMINE STORES. Life Sci (1964) 1.18
Occurrence of fibrinolytic activity following administration of incotinic acid. Proc Soc Exp Biol Med (1959) 1.18
Enzymatic reduction of prontosil and other azo dyes. J Pharmacol Exp Ther (1957) 1.17
The physiological disposition of dicumarol in man. J Pharmacol Exp Ther (1950) 1.17
Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Ann N Y Acad Sci (1959) 1.17
The effect of deoxycorticosterone on the unidirectional transfers of sodium and potassium into and out of the dog intestine. J Physiol (1960) 1.16
Ascorbic acid and the oxidation of tyrosine. Science (1953) 1.16
Role for ganglionic norepinephrine in sympathetic synaptic transmission. Science (1961) 1.15
Effect of feeding egg yolk and cholesterol on serum cholesterol levels. Arch Intern Med (Chic) (1950) 1.15
Interaction of drugs with norepinephrine in the brain. Pharmacol Rev (1959) 1.15
Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system. Experientia (1955) 1.14
Storage synthesis, and metabolism of monoamines in the developing brain. J Neurochem (1962) 1.14
Quinoline and its transformation products found in urine. J Biol Chem (1950) 1.14